Colin Broom
2018
In 2018, Colin Broom earned a total compensation of $2M as Chief Executive Officer at Nabriva Therapeutics AG, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $355,594 |
|---|---|
| Option Awards | $754,400 |
| Salary | $275,137 |
| Stock Awards | $436,725 |
| Other | $223,131 |
| Total | $2,044,987 |
Broom received $754.4K in option awards, accounting for 37% of the total pay in 2018.
Broom also received $355.6K in non-equity incentive plan, $275.1K in salary, $436.7K in stock awards and $223.1K in other compensation.
Rankings
In 2018, Colin Broom's compensation ranked 5,618th out of 14,244 executives tracked by ExecPay. In other words, Broom earned more than 60.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,618 out of 14,244 | 61st |
Division Manufacturing | 2,121 out of 5,759 | 63rd |
Major group Chemicals And Allied Products | 781 out of 2,122 | 63rd |
Industry group Drugs | 653 out of 1,811 | 64th |
Industry Pharmaceutical Preparations | 503 out of 1,385 | 64th |
Source: SEC filing on June 14, 2019.
Broom's colleagues
We found three more compensation records of executives who worked with Colin Broom at Nabriva Therapeutics AG in 2018.